The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment.

International journal of oncology

Volumn 24, Issue 1, 2004, Pages 115-125

  Dart, D Alwyn ^a   Picksley, Steven M ^a   Cooper, Patricia A ^a   Double, John A ^a   Bibby, Michael C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; PROTEIN P53;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG SCREENING; FEMALE; GENETIC TRANSFORMATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MOUSE STRAIN; MUTATION; NEOPLASM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CISPLATIN; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED STRAINS; MICE, NUDE; MUTATION; NEOPLASMS; SACCHAROMYCES CEREVISIAE; TRANSFORMATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 3843128735     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.24.1.115     Document Type: Article

References (0)